A detailed history of Mayar Capital Ltd. transactions in Johnson & Johnson stock. As of the latest transaction made, Mayar Capital Ltd. holds 71,493 shares of JNJ stock, worth $10.3 Million. This represents 12.74% of its overall portfolio holdings.

Number of Shares
71,493
Previous 74,693 4.28%
Holding current value
$10.3 Million
Previous $10.9 Million 6.13%
% of portfolio
12.74%
Previous 10.77%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$145.48 - $167.38 $465,535 - $535,616
-3,200 Reduced 4.28%
71,493 $11.6 Million
Q2 2024

Jul 17, 2024

BUY
$144.38 - $157.78 $922,732 - $1.01 Million
6,391 Added 9.36%
74,693 $10.9 Million
Q1 2024

May 03, 2024

SELL
$155.22 - $162.74 $19,247 - $20,179
-124 Reduced 0.18%
68,302 $10.8 Million
Q4 2023

Feb 08, 2024

BUY
$145.6 - $158.88 $4.84 Million - $5.28 Million
33,227 Added 94.4%
68,426 $10.7 Million
Q1 2023

Apr 25, 2023

BUY
$151.05 - $180.26 $1.11 Million - $1.33 Million
7,351 Added 26.4%
35,199 $5.46 Million
Q4 2022

Jan 20, 2023

SELL
$160.2 - $179.79 $5.3 Million - $5.94 Million
-33,054 Reduced 54.27%
27,848 $4.92 Million
Q3 2022

Oct 18, 2022

SELL
$161.33 - $179.52 $834,882 - $929,016
-5,175 Reduced 7.83%
60,902 $9.95 Million
Q2 2022

Jul 26, 2022

SELL
$168.19 - $186.01 $4.11 Million - $4.54 Million
-24,411 Reduced 26.98%
66,077 $11.7 Million
Q1 2022

Apr 21, 2022

BUY
$158.14 - $179.59 $412,587 - $468,550
2,609 Added 2.97%
90,488 $16 Million
Q4 2021

Jan 28, 2022

BUY
$155.93 - $173.01 $628,241 - $697,057
4,029 Added 4.81%
87,879 $15 Million
Q3 2021

Nov 02, 2021

BUY
$161.5 - $179.47 $1.61 Million - $1.79 Million
9,972 Added 13.5%
83,850 $13.5 Million
Q2 2021

Jul 23, 2021

SELL
$159.48 - $171.07 $162,988 - $174,833
-1,022 Reduced 1.36%
73,878 $12.2 Million
Q1 2021

Apr 26, 2021

BUY
$153.07 - $170.48 $11.5 Million - $12.8 Million
74,900 New
74,900 $12.3 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $378B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Mayar Capital Ltd. Portfolio

Follow Mayar Capital Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mayar Capital Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mayar Capital Ltd. with notifications on news.